Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy

International Journal of Oncology

Volumn 38, Issue 3, 2011, Pages 655-663

  Saigusa, Susumu ^a   Toiyama, Yuji ^a   Tanaka, Koji ^a   Yokoe, Takeshi ^a   Okugawa, Yoshinaga ^a   Fujikawa, Hiroyuki ^a   Matsusita, Kohei ^a   Kawamura, Mikio ^a   Inoue, Yasuhiro ^a   Miki, Chikao ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer associated fibroblasts; Chemoradiotherapy; Fibroblast activation protein ; Rectal cancer; Stromal cell derived factor 1

Indexed keywords

FLUOROURACIL; MESSENGER RNA; SEPRASE; STROMAL CELL DERIVED FACTOR 1; UFT;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CANCER TISSUE; CELL ACTIVATION; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICRODISSECTION; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RECTUM CANCER; RECTUM RESECTION; RNA EXTRACTION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOKINE CXCL12; COMBINED MODALITY THERAPY; FEMALE; FIBROBLASTS; GELATINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MEMBRANE PROTEINS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECTAL NEOPLASMS; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL;

EID: 79952035675     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.906     Document Type: Article

References (35)

1. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731-1740, 2004.
2. Bosset JF, Collette L, Calais G, et al: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355: 1114-1123, 2006. (Pubitemid 44394918)
3. Guillem JG, Chessin DB, Cohen AM, et al: Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 241: 829-838, 2005. (Pubitemid 40604929)
4. Ostman A and Augsten M: Cancer-associated fibroblasts and tumor growth - bystanders turning into key players. Curr Opin Genet Dev 19: 67-73, 2009.
5. Sund M and Kalluri R: Tumor stroma derived biomarkers in cancer. Cancer Metastasis Rev 28: 177-183, 2009.
6. Orimo A and Weinberg RA: Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5: 1597-1601, 2006. (Pubitemid 44285243)
7. Bhowmick NA, Neilson EG and Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337, 2004. (Pubitemid 39551661)
8. Finak G, Bertos N, Pepin F, et al: Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14: 518-527, 2008. (Pubitemid 351655218)
9. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ and Rettig WJ: Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 274: 36505-36512, 1999.
10. Rettig WJ, Su SL, Fortunato SR, et al: Fibroblast activation protein: purification, epitope mapping and induction by growth factors. Int J Cancer 58: 385-392, 1994. (Pubitemid 24254649)
11. Skubitz KM and Skubitz AP: Gene expression in aggressive fibromatosis. J Lab Clin Med 143: 89-98, 2004. (Pubitemid 38241560)
12. Huang Y, Wang S and Kelly T: Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer. Cancer Res 64: 2712-2716, 2004. (Pubitemid 38500606)
13. Lee J, Fassnacht M, Nair S, Boczkowski D and Gilboa E: Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts. Cancer Res 65: 11156-11163, 2005. (Pubitemid 41713387)
14. Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001. (Pubitemid 32225831)
15. Orimo A, Gupta PB, Sgroi DC, et al: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005. (Pubitemid 40692295)
16. Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S and Tosato G: Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 99: 2703-2711, 2002. (Pubitemid 34525355)
17. Matsusue R, Kubo H, Hisamori S, et al: Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann Surg Oncol 16: 2645-2653, 2009.
18. Yoshitake N, Fukui H, Yamagishi H, et al: Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Br J Cancer 98: 1682-1689, 2008. (Pubitemid 351684689)
19. Yoshikawa R, Kusunoki M, Yanagi H, et al: Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res 61: 1029-1037, 2001. (Pubitemid 32174421)
20. Japanese Society for Cancer of the Colon and Rectum: General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus. 7th edition. Kanehara & Co., Tokyo, 2006.
21. Bijwaard KE, Aguilera NS, Monczak Y, Trudel M, Taubenberger JK and Lichy JH: Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma. Clin Chem 47: 195-201, 2001. (Pubitemid 32142916)
22. Potenta S, Zeisberg E and Kalluri R: The role of endothelial-to- mesenchymal transition in cancer progression. Br J Cancer 99: 1375-1379, 2008.
23. Karnoub AE, Dash AB, Vo AP, et al: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563, 2007. (Pubitemid 47525152)
24. Koukourakis MI, Giatromanolaki A, Harris AL and Sivridis E: Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 66: 632-637, 2006. (Pubitemid 43165922)
25. Hwang RF, Moore T, Arumugam T, et al: Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68: 918-926, 2008. (Pubitemid 351206771)
26. Henry LR, Lee HO, Lee JS, et al: Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res 13: 1736-1741, 2007. (Pubitemid 46952939)
27. Iwasa S, Jin X, Okada K, Mitsumata M and Ooi A: Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. Cancer Lett 199: 91-98, 2003. (Pubitemid 37088142)
28. Tse JC and Kalluri R: Mechanisms of metastasis: Epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 101: 816-829, 2007. (Pubitemid 47040864)
29. Zeisberg EM, Potenta S, Xie L, Zeisberg M and Kalluri R: Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67: 10123-10128, 2007. (Pubitemid 350070783)
30. Tsukamoto H, Shibata K, Kajiyama H, Terauchi M, Nawa A and Kikkawa F: Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells. Gynecol Oncol 107: 500-504, 2007. (Pubitemid 350160864)
31. Onoue T, Uchida D, Begum NM, Tomizuka Y, Yoshida H and Sato M: Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. Int J Oncol 29: 1133-1138, 2006.
32. Loeffler M, Kruger JA, Niethammer AG and Reisfeld RA: Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest 116: 1955-1962, 2006.
33. Pietras K, Ostman A, Sjoquist M, et al: Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 61: 2929-2934, 2001. (Pubitemid 32691937)
34. Naber HP, ten Dijke P and Pardali E: Role of TGF-beta in the tumor stroma. Curr Cancer Drug Targets 8: 466-472, 2008.
35. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458, 2003.